|
|
|
|
|
|
|
|
|
|
Roche will report new data on important progress for people with advanced cancers at ASCO 2012
Data from AURELIA, the first Phase III study of Avastin plus chemotherapy in people with platinum-resistant recurrent ovarian cancer will be presented. This study will be highlighted as part of ASCO’s official press program.
0 comments :
Post a Comment
Your comments?
Note: Only a member of this blog may post a comment.